Literature DB >> 20309934

Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model.

Kiron M Das1, Yingxin Kong, Manisha Bajpai, Diptee Kulkarni, Xin Geng, Pravin Mishra, Debabrata Banerjee, Kim Hirshfield.   

Abstract

The mechanism by which gastroesophageal reflux promotes metaplasiadysplasia→carcinoma is unknown. The aim of the study is to determine if repeated exposure to acid and bile confers a tumorigenic phenotype in a telomerase (hTERT)-immortalized benign Barrett's cell line (BAR-T). BAR-T cells were exposed to acid (pH 4) (A) and bile salt (200 μM glycochenodeoxycholic acid) (B) daily for 5 min up to 65+ weeks. The control cells were grown in parallel without any A or B treatment. Cell morphology, proliferation, transformation, and molecular changes in the gene expression for COX-2, TC22, p53 and p53 target genes were analyzed at 8-12 weeks intervals. At 46 weeks BAR-T cells exposed to (A+B) showed distinct phenotypic changes: forming clusters and acini, and at 65 weeks displayed foci in monolayer, and formed distinct colonies in soft agar. Untreated cells did not show any such changes. In A+B-treated BAR-T cells, COX-2 mRNA increased 10- to 20-fold, TC22 mRNA increased by 2- to 3-fold at 22-65 weeks, p53, MDM2, PERP, and p21mRNA increased 2.5-, 6.4-, 4-, and 2.6-fold respectively when compared to untreated cells at 34 weeks. However, at 58 weeks onward, there was a sharp decline of p53 and its target genes to the baseline level. At 65 weeks A+B-treated BAR-T cells formed tumor in nude mice whereas untreated cells did not. We demonstrate a novel in vitro model of transformation of a benign Barrett's cell line following repeated exposure to A+B over the course of 65 weeks.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309934      PMCID: PMC3876418          DOI: 10.1002/ijc.25343

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  46 in total

1.  Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody.

Authors:  K M Das; I Prasad; S Garla; P S Amenta
Journal:  Ann Intern Med       Date:  1994-05-01       Impact factor: 25.391

2.  Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis.

Authors:  X Geng; L Biancone; H H Dai; J J Lin; N Yoshizaki; A Dasgupta; F Pallone; K M Das
Journal:  Gastroenterology       Date:  1998-05       Impact factor: 22.682

3.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 4.  The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.

Authors:  S J Spechler; R K Goyal
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

5.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis.

Authors:  T S Halstensen; K M Das; P Brandtzaeg
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

6.  Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus.

Authors:  N Katada; R A Hinder; T C Smyrk; N Hirabayashi; G Perdikis; R J Lund; T Woodward; P J Klingler
Journal:  Arch Surg       Date:  1997-07

7.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

8.  Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma.

Authors:  M V González; M L Artímez; L Rodrigo; C López-Larrea; M J Menéndez; V Alvarez; R Pérez; M F Fresno; M J Pérez; A Sampedro; E Coto
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

9.  Molecular analysis of the TP53 gene in Barrett's adenocarcinoma.

Authors:  M P Audrézet; M Robaszkiewicz; B Mercier; J B Nousbaum; E Hardy; J P Bail; A Volant; P Lozac'h; H Gouérou; C Férec
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

10.  Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.

Authors:  T T Wu; T Watanabe; R Heitmiller; M Zahurak; A A Forastiere; S R Hamilton
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

View more
  20 in total

1.  Activin A-mediated epithelial de-differentiation contributes to injury repair in an in vitro gastrointestinal reflux model.

Authors:  Cedric Roudebush; Alma Catala-Valentin; Thomas Andl; Gregoire F Le Bras; Claudia D Andl
Journal:  Cytokine       Date:  2019-07-29       Impact factor: 3.861

2.  Development and characterization of an organotypic model of Barrett's esophagus.

Authors:  Rachelle E Kosoff; Kristin L Gardiner; Lauren M F Merlo; Kirill Pavlov; Anil K Rustgi; Carlo C Maley
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

3.  Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.

Authors:  Qiuyang Zhang; Agoston T Agoston; Thai H Pham; Wei Zhang; Xi Zhang; Xiaofang Huo; Sui Peng; Manisha Bajpai; Kiron Das; Robert D Odze; Stuart J Spechler; Rhonda F Souza
Journal:  Gastroenterology       Date:  2018-09-27       Impact factor: 22.682

4.  Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis.

Authors:  Aaron Goldman; Hwu Dau Rw Chen; Heather B Roesly; Kimberly A Hill; Margaret E Tome; Bohuslav Dvorak; Harris Bernstein; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-02       Impact factor: 4.052

5.  Silencer-of-Death Domain Mediates Acid-Induced Decrease in Cell Apoptosis in Barrett's Associated Esophageal Adenocarcinoma Cells.

Authors:  Dan Li; Jie Hong; Weibiao Cao
Journal:  J Pharmacol Exp Ther       Date:  2016-10-18       Impact factor: 4.030

6.  Prevention of DNA damage in Barrett's esophageal cells exposed to acidic bile salts.

Authors:  Vikas Bhardwaj; Andela Horvat; Olga Korolkova; Mary K Washington; Wael El-Rifai; Sergey I Dikalov; Alexander I Zaika
Journal:  Carcinogenesis       Date:  2016-09-21       Impact factor: 4.944

7.  Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational cross-sectional study.

Authors:  Lu Yao Zhang; Jian Zhang; Dan Li; Yuan Liu; Dong Ling Zhang; Cai Fang Liu; Na Wang; Si Ran Wu; Wen Quan Lu; Jing Zhi Guo; Yong Quan Shi
Journal:  J Dig Dis       Date:  2021-05-06       Impact factor: 2.325

Review 8.  Mechanisms of Barrett's oesophagus: intestinal differentiation, stem cells, and tissue models.

Authors:  Hiroshi Nakagawa; Kelly Whelan; John P Lynch
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-11-12       Impact factor: 2.695

9.  Recurring Translocations in Barrett's Esophageal Adenocarcinoma.

Authors:  Manisha Bajpai; Anshuman Panda; Kristen Birudaraju; James Van Gurp; Amitabh Chak; Kiron M Das; Parisa Javidian; Hana Aviv
Journal:  Front Genet       Date:  2021-06-09       Impact factor: 4.599

10.  Prolonged exposure to acid and bile induces chromosome abnormalities that precede malignant transformation of benign Barrett's epithelium.

Authors:  Manisha Bajpai; Hana Aviv; Kiron M Das
Journal:  Mol Cytogenet       Date:  2012-11-29       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.